AFK Journey x Fairy Tail Crossover Is Now Live!

The much-anticipated AFK Journey x Fairy Tail crossover event is now live, marking the game's first-ever collaboration. This thrilling event, dubbed Fairy Sonata, is set to run for 28 days, giving you until May 28th to explore the new content and claim the exclusive characters.

What’s in Store?

Farlight Games, the masterminds behind AFK Journey, have joined forces with the beloved anime Fairy Tail to introduce Natsu Dragneel and Lucy Heartfilia into the enchanting world of Esperia. This crossover comes packed with an original storyline that promises genuine stakes and engaging content.

In this unique narrative, Natsu and Lucy find themselves transported to Esperia via a mysterious portal. Both characters are added to the game as new dimensional faction heroes. Lucy, driven by the quest to recover something precious she's lost, crosses paths with AFK Journey's Valen and Cassadee. Together, along with the wise Merlin, they embark on a thrilling journey filled with magical battles and perilous quests.

More About the New Characters in the AFK Journey x Fairy Tail Collab

Lucy wields her Celestial Spirit Magic and Gate Keys to summon celestial spirits, including those from the Zodiac set. Recognizable by her pink Fairy Tail guild mark on her right hand, she shares a profound bond with her spirits.

Natsu, also known as Salamander, is a Dragon Slayer Mage with an aversion to any form of transportation. Sporting a red guild mark on his right shoulder, his fiery spirit is set to ignite the gameplay in AFK Journey. You can get a sneak peek of these new heroes in the official trailer below.

The Fairy Sonata event offers a plethora of stages to conquer, stories to unlock, and daily quests to complete. As an added bonus, simply logging in will grant you 30 free event recruits, enhancing your journey through this limited-time extravaganza.

Don't miss out on this exciting crossover! Download AFK Journey from the Google Play Store and immerse yourself in the Fairy Sonata event today.